Article Text

PDF
Letter
Changes in the use of humidified high flow nasal cannula oxygen
  1. Sandeep Shetty1,2,
  2. Adesh Sundaresan1,
  3. Katie Hunt2,
  4. Prakash Desai3,
  5. Anne Greenough1,2,4
  1. 1Division of Asthma, Allergy and Lung Biology, MRC and Asthma UK Centre in Allergic Mechanisms of Asthma, King's College London, London, UK
  2. 2Department of Child Health, Neonatal Intensive Care Centre, King's College Hospital, London, UK
  3. 3Neonatal Intensive Care Unit, Chelsea and Westminster Hospital, London, UK
  4. 4NIHR Biomedical Centre at Guy's and St Thomas NHS Foundation Trust and King's College London, London, UK
  1. Correspondence to Professor Anne Greenough, NICU, 4th Floor Golden Jubilee Wing, King's College Hospital, Denmark Hill, London SE5 9RS, UK; anne.greenough{at}kcl.ac.uk

Statistics from Altmetric.com

Humidified high flow nasal cannula (HHFNC) has gained popularity in neonatal care. A systematic review1 of the results of nine trials, which included a total of 1112 infants, however, demonstrated that HHFNC was not superior to other modes of non-invasive ventilation in infants of >28 weeks gestational age. We, therefore, sought to determine whether clinical practice regarding HHFNC had changed since 2012 when all UK units were surveyed2 and also to identify why practitioners preferred HHFNC or continuous positive airway pressure (CPAP).

In 2015, lead clinicians of all 194 UK neonatal units were identified from the National Neonatal Audit …

View Full Text

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles

  • Fantoms
    Ben Stenson